Anastasis: A Novel Cell Survival Mechanism
Anastasis:一种新的细胞生存机制
基本信息
- 批准号:10713750
- 负责人:
- 金额:$ 40.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-22 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:AnimalsApoptosisApoptoticBioinformaticsBiosensorBrain InjuriesCASP3 geneCancer cell lineCardiac MyocytesCell DeathCell Death InductionCell Death ProcessCell Differentiation processCell Membrane PermeabilityCell SurvivalCellsCessation of lifeCytoprotectionDrosophila genusEmbryonic DevelopmentEventExhibitsFoundationsGenesGeneticHeart failureHomeostasisHumanIn VitroKnowledgeLabelMammalian CellMolecularMorphologyMusNeuronsOuter Mitochondrial MembranePathologicPhysiologicalPlayPost-Translational Protein ProcessingProteinsProteomicsRattusRecoveryRecurrenceRecurrent diseaseRegulationRoleSystemTestingTherapeuticTissuesXenograft procedurecancer cellcancer survivalcancer therapyclinically relevanteggin vivoinsightmouse modelnovelnovel therapeutic interventionpharmacologicpreservationsmall moleculestable cell linetherapeutic targettool
项目摘要
Anastasis: A Novel Cell Survival Mechanism
Project Summary
Anastasis is a newly discovered cell recovery mechanism that rescues apoptotic cells from the brink of death.
Challenging the classic view of irreversible apoptosis, we have discovered robust reversibility of apoptosis in
three types of mouse/rat primary cells, twelve human cancer cell lines, and egg chambers in fruit flies. What are
the physiological functions, pathological roles, and therapeutic potentials of anastasis? Anastasis could
be an unexpected cytoprotective mechanism for preserving terminally differentiated cells and tissues that are
difficult to replace, such as cardiomyocytes and neurons. If true, enhancing anastasis may be beneficial for
treating heart failure and brain injury. Besides, anastasis could be an unrecognized escape tactic enabling cancer
cells to survive cancer therapy, thereby contributing to disease recurrence. If confirmed, suppressing anastasis
in dying cancer cells may promote cancer cell death and reduce the chances of recurrence. Anastasis may also
play important roles in limiting apoptosis during embryonic development and normal homeostasis. If identified,
understanding its regulation can provide new insights into the control of cell death and survival in physiological
conditions. However, there are several challenges of testing these hypotheses. It is difficult to track anastasis,
especially in vivo, because cells that have reversed apoptosis are morphologically indistinguishable from healthy
cells. There are no anastasis-specific hallmarks identified, and the regulators of anastasis remain undiscovered.
Here, we will overcome many of these challenges by developing a novel and highly specific tracking system to
label anastatic cells for mammalian studies, and to identify the key regulators of anastasis. To mark anastatic
cells, we will create an anastasis biosensor that can tag anastatic cells with permanent expression of a
fluorescent protein only after they have recovered from both mitochondrial outer membrane permeabilization
(MOMP) and caspase-3 activation, the two most recognized apoptotic events, making this biosensor system
highly specific to anastasis. We will establish anastasis biosensor stable cell lines to determine reversibility of
apoptosis in vitro, and will employ biosensor xenografts to interrogate anastasis in vivo using clinically relevant
mouse models. To elucidate the mechanism of anastasis, we will identify its key regulators, through proteomics,
genetics, and pharmacological approaches. We will identify which genes exhibit up- or down-expression
(potential anastasis regulators, and therapeutic targets) during different stages of anastasis, determine whether
specific post-translational modifications distinguish anastatic cells, establish whether cells that recover from
different cell death inductions share similar molecular features, and investigate how interfering with anastasis
regulator candidates could modulate the reversibility of apoptosis. We will identify small molecules that target
the candidates by bioinformatics, and test their efficacy in promoting or suppressing anastasis in vitro.
Successful completion of this project will generate essential tools and knowledge for studying anastasis, thereby
laying a strong foundation for developing revolutionary new therapeutic approaches by controlling anastasis.
Anastasis:一种新的细胞生存机制
项目摘要
Anastasis是一种新发现的细胞恢复机制,可将凋亡细胞从死亡边缘拯救出来。
支持不可逆细胞凋亡的经典观点,我们已经发现了细胞凋亡的强大可逆性,
三种类型的小鼠/大鼠原代细胞,十二种人类癌细胞系,以及果蝇的卵室。是什么
吻合的生理功能、病理作用和治疗潜力?Anastasis可以
是一种意想不到的细胞保护机制,用于保存终末分化的细胞和组织,
难以替代的细胞,如心肌细胞和神经元。如果是真的,增强吻合可能对
治疗心力衰竭和脑损伤此外,anastasis可能是一种未被识别的逃避策略,
细胞在癌症治疗中存活,从而有助于疾病复发。如果证实,抑制愈合
在垂死的癌细胞中,可能会促进癌细胞死亡,减少复发的机会。Anastasis也可以
在胚胎发育和正常体内平衡过程中限制细胞凋亡中起重要作用。如果被发现,
了解它的调节可以提供新的见解,控制细胞死亡和生存的生理
条件然而,测试这些假设存在一些挑战。很难追踪anastasis,
特别是在体内,因为逆转凋亡的细胞在形态上与健康细胞无法区分,
细胞目前还没有发现anastasis的特异性标志,anastasis的调节因子也尚未发现。
在这里,我们将通过开发一种新颖且高度特异性的跟踪系统来克服其中的许多挑战,
标记哺乳动物研究的anastatic细胞,并确定anastasis的关键调节因子。为了马克·阿纳斯塔西娅
细胞,我们将创建一个anastasis生物传感器,可以标记anastasis细胞与永久表达
荧光蛋白只有在它们从线粒体外膜透化中恢复后才能产生
(MOMP)和caspase-3激活,这是两种最常见的细胞凋亡事件,使该生物传感器系统
对anastasis有很强的特异性。我们将建立anastasis生物传感器稳定的细胞系,以确定可逆性,
细胞凋亡,并将采用生物传感器异种移植物,使用临床相关的
小鼠模型。为了阐明anastasis的机制,我们将通过蛋白质组学鉴定其关键调控因子,
遗传学和药理学方法。我们将确定哪些基因表现出上调或下调表达,
(潜在的促渗调节剂和治疗靶点)在促渗的不同阶段,
特定的翻译后修饰可以区分无主枝细胞,确定从无主枝细胞恢复的细胞是否
不同的细胞死亡诱导具有相似的分子特征,并研究了如何干扰细胞凋亡。
调节剂候选物可以调节凋亡的可逆性。我们将识别出小分子,
通过生物信息学方法筛选候选物,并在体外测试其促进或抑制愈合的功效。
该项目的成功完成将为研究anastasis提供必要的工具和知识,
为通过控制回输来开发革命性的新治疗方法奠定了坚实的基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ho Lam Tang其他文献
Ho Lam Tang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ho Lam Tang', 18)}}的其他基金
Elucidating connections between anastasis and cancer drug resistance
阐明吻合与癌症耐药性之间的联系
- 批准号:
10056879 - 财政年份:2020
- 资助金额:
$ 40.94万 - 项目类别:
Cell survival by anastasis, a novel therapeutic target in cancer
细胞存活通过吻合,癌症的新治疗靶点
- 批准号:
9751798 - 财政年份:2017
- 资助金额:
$ 40.94万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
- 批准号:
10596657 - 财政年份:2021
- 资助金额:
$ 40.94万 - 项目类别:
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
- 批准号:
10417219 - 财政年份:2021
- 资助金额:
$ 40.94万 - 项目类别:
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2015
- 资助金额:
$ 40.94万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2014
- 资助金额:
$ 40.94万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Understanding the activation of pro-apoptotic Bcl-2 family proteins for the development of modulators of apoptosis
了解促凋亡 Bcl-2 家族蛋白的激活以开发凋亡调节剂
- 批准号:
nhmrc : 1059331 - 财政年份:2014
- 资助金额:
$ 40.94万 - 项目类别:
Project Grants
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2013
- 资助金额:
$ 40.94万 - 项目类别:
Postgraduate Scholarships - Doctoral
Apoptotic Osteocytes Promote Chondrocyte Apoptosis via Soluble Factors
凋亡骨细胞通过可溶性因子促进软骨细胞凋亡
- 批准号:
251802 - 财政年份:2012
- 资助金额:
$ 40.94万 - 项目类别:
Studentship Programs
Defining the mechanism(s) by which the cellular inhibitor of apoptosis protein 2 (cIAP2) contributes to early stage atherosclerosis development by directly promoting the participation of key apoptotic pathways within lesion-associated macrophages
确定凋亡蛋白细胞抑制剂 2 (cIAP2) 通过直接促进病变相关巨噬细胞内关键凋亡途径的参与来促进早期动脉粥样硬化发展的机制
- 批准号:
191299 - 财政年份:2009
- 资助金额:
$ 40.94万 - 项目类别:
Operating Grants
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
- 批准号:
8075522 - 财政年份:2009
- 资助金额:
$ 40.94万 - 项目类别:
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
- 批准号:
7676912 - 财政年份:2009
- 资助金额:
$ 40.94万 - 项目类别: